Digital pathology company 3Scan has raised a $14 million Series B to flesh out its image processing and analysis software and to increase its presence in the drug discovery field. Lux Capital and Data ...
SAN FRANCISCO, March 1, 2018 /PRNewswire/ -- 3Scan, the 3D digital and computational pathology company, today announced the addition of Steve England, Ph.D., to their leadership team as Chief Science ...
SAN MATEO, Calif., Sept. 5, 2018 /PRNewswire-PRWeb/ -- Vium, Inc. http://www.vium.com, the leading innovator for in vivo research applying its Digital Vivarium ...
SAN FRANCISCO--(BUSINESS WIRE)--3Scan, (www.3scan.com), developer of transformative technologies for pathology and a revolutionary new Knife Edge Scanning Microscope (KESM) for powerful, rapid ...
This one’s a big data play for the pathologist set: Bay Area startup 3Scan is developing an ultra high-res, 3-D tissue imaging platform that’s churning out data on the scale of whole-genome sequencing ...
Forbes contributors publish independent expert analyses and insights. I write as VC on emerging technology, science & finance. My background is in bioinformatics, the use of computation to understand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback